Skip to main content
. 2021 Jun 17;11:12765. doi: 10.1038/s41598-021-91917-6

Table 2.

Characteristics of subjects consuming fermented milk products containing Lacticaseibacillus paracasei strain Shirota (LcS) < 3 or ≥ 3 days per week over the past 10-year period.

 < 3 days/week  ≥ 3 days/week
n Mean ± SD n Mean ± SD
Anthropometric parameters
Age (years) 160 75.1 ± 6.3 58 76.0 ± 6.0
Sex (male/female, %) 160 48.8/51.3 58 36.2/63.8
Height (m) 160 1.57 ± 0.09 58 1.55 ± 0.09
Body mass (kg) 160 55.9 ± 10.6 58 54.5 ± 9.1
Body mass index (kg/m2) 160 22.7 ± 3.3 58 22.5 ± 2.7
Physical health measurements
Systolic blood pressure (mmHg) 157 125.7 ± 16.3 56 130.1 ± 19.0
Diastolic blood pressure (mmHg) 157 73.9 ± 10.1 56 74.6 ± 9.8
Preferred walking speed (m/s) 145 1.40 ± 0.20 50 1.41 ± 0.15
Maximal walking speed (m/s) 144 2.00 ± 0.37 50 1.98 ± 0.30
Peak handgrip force (N) 149 274.5 ± 78.5 53 262.8 ± 81.2
Calcaneal osteosonic index (× 106) 151 2.42 ± 0.36 54 2.38 ± 0.30
Defecation status
Defecation frequency (days/week) 160 6.1 ± 1.5 58 5.9 ± 1.7
Bristol stool form scale score 160 4.0 ± 0.9 58 3.9 ± 0.9
Habitual physical activity patterns
Step count (steps/day) 151 7085 ± 3041 54 7053 ± 3102
Duration of exercise > 3 metabolic equivalents (min/day) 151 17.2 ± 14.2 54 15.6 ± 14.1
Current smoking and drinking habits
Smoker (number [%]) 160 9 [5.6] 58 1 [1.7]
Alcohol consumer (number [%]) 160 73 [45.6] 58 13 [22.4]**
Medication states
Antibiotics (number [%]) 160 2 [1.3] 58 1 [1.7]
Gastric acid lowering medicines (number [%]) 160 31 [19.4] 58 17 [29.3]
Nutrient intakes
Energy (kcal/day) 152 2166 ± 624 54 2230 ± 520
Protein (g/day) 152 81.7 ± 26.2 54 82.0 ± 20.1
Lipid (g/day) 152 73.3 ± 28.1 54 74.8 ± 25.6
Carbohydrate (g/day) 152 279 ± 75 54 297 ± 65
Dietary fiber (g/day) 152 17.5 ± 5.8 54 18.5 ± 4.3
Saturated fatty acid (g/day) 152 22.6 ± 9.2 54 22.6 ± 7.6
Monounsaturated fatty acid (g/day) 152 24.6 ± 10.2 54 24.0 ± 8.2
Polyunsaturated fatty acid (g/day) 152 15.7 ± 6.1 54 15.4 ± 5.1
Cholesterol (mg/day) 152 373 ± 131 54 359 ± 109
Sodium (mg/day) 152 4753 ± 2053 54 4788 ± 1272
Potassium (mg/day) 152 3004 ± 1035 54 3100 ± 800
Calcium (mg/day) 152 788 ± 273 54 847 ± 249
Magnesium (mg/day) 152 317 ± 105 54 321 ± 77
Iron (mg/day) 152 9.70 ± 3.47 54 10.6 ± 3.58
Vitamin C (mg/day) 152 125 ± 52 54 142 ± 49*
Blood profiles
Triglyceride (mmol/l) 124 1.47 ± 0.75 48 1.40 ± 0.76
High-density lipoprotein cholesterol (mmol/l) 124 1.63 ± 0.58 48 1.68 ± 0.45
Low-density lipoprotein cholesterol (mmol/l) 124 3.10 ± 0.75 48 3.27 ± 0.65
Glycosylated hemoglobin A1c (%) 124 5.65 ± 0.50 48 5.56 ± 0.34
Blood sugar (mmol/l) 124 6.22 ± 1.44 48 5.93 ± 0.98
Glutamic oxaloacetic transaminase (IU/l) 124 23.9 ± 7.3 48 25.2 ± 6.2
Glutamic pyruvic transaminase (IU/l) 124 19.7 ± 8.5 48 19.0 ± 7.2
γ-Glutamyl transpeptidase (IU/l) 124 29.3 ± 29.0 48 22.5 ± 13.7
Albumin (g/l) 124 42.9 ± 3.0 48 43.6 ± 3.2
Creatinine (μmol/l) 124 76.6 ± 55.7 48 69.8 ± 15.5
Uric acid (μmol/l) 124 300 ± 76 48 293 ± 71
Estimated glomerular filtration rate (ml/min/1.73 m2) 124 63.3 ± 14.3 48 61.7 ± 9.6

Intergroup differences in the ratio of male/female, smoker/nonsmoker, alcohol consumer/non-alcohol consumer, and medicated/non-medicated were assessed by chi-square tests. Independent differences in each of the other variables between groups were assessed by analyses of covariance, after adjusting data on age for sex and the others for age and sex. *P < 0.05, **P < 0.01 versus < 3 days/week.

Data on 1-month and 5-year periods are not shown, mainly because of their similarities to those on a 10-year period.